CardioGenics Holdings (CardioGenics Holdings) FCF Margin % : 0.00% (As of Jan. 2016)

View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CardioGenics Holdings's Free Cash Flow for the three months ended in Jan. 2016 was $0.03 Mil. CardioGenics Holdings's Revenue for the three months ended in Jan. 2016 was $0.00 Mil. Therefore, CardioGenics Holdings's FCF Margin % for the quarter that ended in Jan. 2016 was 0.00%.

As of today, CardioGenics Holdings's current FCF Yield % is 0.00%.

The historical rank and industry rank for CardioGenics Holdings's FCF Margin % or its related term are showing as below:

CGNH's FCF Margin % is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: -10.405
* Ranked among companies with meaningful FCF Margin % only.

CardioGenics Holdings FCF Margin % Historical Data

The historical data trend for CardioGenics Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings FCF Margin % Chart

CardioGenics Holdings Annual Data

Trend

Jul06

Jul07

Jul08

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Oct15

FCF Margin %

Get a 7-Day Free Trial

-17,266.67

-97,900.00

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of CardioGenics Holdings's FCF Margin %

For the Diagnostics & Research subindustry, CardioGenics Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CardioGenics Holdings's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's FCF Margin % falls into.

CardioGenics Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

CardioGenics Holdings's FCF Margin for the fiscal year that ended in Oct. 2015 is calculated as

FCF Margin	=	Free Cash Flow (A: Oct. 2015 )	/	Revenue (A: Oct. 2015 )
	=	-0.609	/	0
	=	%

CardioGenics Holdings's FCF Margin for the quarter that ended in Jan. 2016 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jan. 2016 )	/	Revenue (Q: Jan. 2016 )
	=	0.03	/	0
	=	%

CardioGenics Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8

Website

http://www.cardiogenics.com

CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines